Integrated Research Limited provided revenue guidance for the full year 2023. Subject to audit, the company expected the TCV result to translate into reported statutory revenue in the range of $39 million - $42 million for the period, an increase of 1% - 9% on the pcp. On a pro-forma basis, revenue is anticipated to be in the range of $36 million - $38 million, down -6% - 0% on the pcp, reflecting lower recurring (licence) revenue.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.43 AUD | +4.88% | +22.86% | +19.44% |
Mar. 06 | Cathy Aston Resigns as Director of Integrated Research Limited, Effective 31 March 2024 | CI |
Feb. 22 | Transcript : Integrated Research Limited, H1 2024 Earnings Call, Feb 22, 2024 |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+19.44% | 46.69M | |
+6.69% | 3,020B | |
+5.47% | 82.93B | |
+3.18% | 76.85B | |
-15.18% | 53.04B | |
+32.15% | 50.15B | |
-25.75% | 46.71B | |
+16.94% | 41.41B | |
+58.62% | 36.1B | |
-10.43% | 24.64B |
- Stock Market
- Equities
- IRI Stock
- News Integrated Research Limited
- Integrated Research Limited Provides Revenue Guidance for the Full Year 2023